Quantitative evaluation of the efficacy and safety of first-line systemic therapies for advanced hepatocellular carcinoma.

Objectives: This study aimed to quantitatively evaluate the efficacy and safety of first-line systemic therapies for treating advanced hepatocellular carcinoma (aHCC). Methods: The study included clinical trials of first-line systemic therapies for aHCC since the approval of sorafenib in 2007. Hazar...

Descripción completa

Detalles Bibliográficos

Publicado en:	European Journal of Clinical Pharmacology Vol. 81; no. 3; pp. 383 - 394
Autores principales:	Wang, Xinrui, Huang, Jihan, Liu, Yixiao, Wu, Lijuan, Cai, Ruifen, Zheng, Qingshan, Li, Lujin
Formato:	research tables/charts Journal Article
Publicado:	Springer Nature Mar2025
Acceso en línea:	Ver este registro en EBSCOhost